Fedenia Advisers »

Cartesian Therapeutics shares owned by Fedenia Advisers

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Fedenia Advisers from 13F filings

Historical chart of Fedenia Advisers investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Fedenia Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Fedenia Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $297k 29k 10.42

More positions owned by Fedenia Advisers

Invesco Qqq Trust Series I Etf (QQQ)
State Street Spdr S&p 500 Etf Etf (SPY)
Ishares National Muni Bond Etf Etf (MUB)
Sandisk Corp Stock (SNDK)
Vanguard S&p 500 Etf Etf (VOO)
Micron Technology Stock (MU)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Western Digital Corp Stock (WDC)
Advanced Micro Devices Stock (AMD)
Seagate Technology Hldngs Plc Ord Stock (STX)
Lam Research Corp Stock (LRCX)
Marvell Technology Stock (MRVL)
Applied Matls Stock (AMAT)
Palo Alto Networks Stock (PANW)
Ishares Long-term National Muni Bond Etf Etf (LMUB)

View all positions for Fedenia Advisers

Top funds holding Cartesian Therapeutics

Squarepoint Ops
BlackRock
683 Capital Management
Vanguard Capital Management
FMR
Geode Capital Management
AQR Capital Management
Millennium Management
Two Sigma Investments
Marshall Wace
UBS Group
Jupiter Topco
State Street Corporation
Privium Fund Management B.V.
Susquehanna International

View all funds holding Cartesian Therapeutics